G005955

HPLC Analysis of HSA Fusion Protein on Zenix^®-C SEC-300, Effect of Mobile Phase Composition

application for HPLC

属性

• 技術: HPLC: suitable
• 測試參數: column: Zenix-C SEC-300, 30 cm x 7.8 mm I.D., 3 μm particles (Z777092); mobile phase: 150 mM sodium phosphate buffer, pH 7.0 or (A) 150 mM sodium phosphate buffer, pH 7.0; (B) IPA; (95:5, A:B); flow rate: 1.0 mL/min; column temp.: 25 °C; detector: UV, 280 nm; injection: 10 μL; sample: HSA fusion peptide 5 mg/mL (MW 75 kD, pl 5.0, HSA conjugated peptide in diabetes treatment)
• 適合性: application for HPLC
• 應用: life science and biopharma

说明

法律資訊

Zenix is a registered trademark of Sepax Technologies